A polymerisable aptamer incorporated into Molecularly Imprinted Polymer nanoparticles (MIPs) creates a hybrid “best-of-both-worlds” approach which outperforms individual constituent components.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: